Cell-to-Cell Variability in PI3K Protein Level Regulates PI3K-AKT Pathway Activity in Cell Populations
Open Access
- 8 February 2011
- journal article
- Published by Elsevier BV in Current Biology
- Vol. 21 (3), 173-183
- https://doi.org/10.1016/j.cub.2010.12.047
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Regulated Fluctuations in Nanog Expression Mediate Cell Fate Decisions in Embryonic Stem CellsPLoS Biology, 2009
- Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941Molecular Cancer Therapeutics, 2009
- Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosisNature, 2009
- Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenograftsBritish Journal of Cancer, 2009
- Dynamic Proteomics of Individual Cancer Cells in Response to a DrugScience, 2008
- Nature, Nurture, or Chance: Stochastic Gene Expression and Its ConsequencesCell, 2008
- PI3K pathway alterations in cancer: variations on a themeOncogene, 2008
- Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic DrugsCancer Cell, 2008
- Transcriptome-wide noise controls lineage choice in mammalian progenitor cellsNature, 2008
- Stochastic switching as a survival strategy in fluctuating environmentsNature Genetics, 2008